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FINAL PROGRESS REPORT 
Individual Postdoctoral National Research Service Award for R. Richard Plaskon 
S F32 HL07994-03 BI-4 
Sponsored by F.L. Suddath 
Much of the training goals and research aims of the fellowship were satisfied. However, 
inadequacies in the application of available computational methods to accomplish the research aims 
necessitated the development of novel uses for the available methods. The amount of time devoted to 
this effort prevented the use of molecular dynamics and allowed only two enzymes to be studied. 
Nonetheless, valuable experience in the molecular modeling (excluding molecular dynamics) of serine 
proteases and their interactions with inhibitors was obtained. The quantum mechanical (QM) 
calculations performed resulted in much experience in using the semiempirical QM package MOP AC 
(QCPE, Indiana University). Many papers were read and discussions held on the inhibition of serine 
proteases and computational procedures of possible use in modeling serine protease inhibition as well 
as protein-ligand interactions. 
The research performed on porcine pancreatic elastase (PPE) resulted in the development of a 
method useful for the design of potent PPE inhibitors. The method produced results consistent with 
the potency of six 7-substituted 4-chloro-3-ethoxyisocoumarin inhibitors ofPPE and led to the 
synthesis of the most potent inhibitor of this class of PPE inhibitors. This novel inhibitor is as potent 
as predicted by the method. The molecular mechanics program, CHARMm of the Polygen Corp. 
(Waltham, MA 02254 ), used for the method provides a set of atomic point charges necessary for the 
electrostatic portion of the calculations. Inclusion of these charges produced results inconsistent with 
inhibitor potency. Only with charges derived from a MOP AC calculation is the method useful for the 
prediction of inhibitor potency toward PPE. A portion of the results with PPE have been published in 
the journal Proteins and another portion submitted for publication in Archives of Biochemistry and 
Biophysics. 
To determine if the method developed with PPE is suitable for the design of inhibitors for a 
medically important enzyme, inhibition of human leukocyte elastase (HLE) by 7-substituted 3-alkoxy-
4-chloroisocoumarins was modeled. Unlike PPE, the x-ray structure of the native form of HLE is not 
known and only structures complexed with peptide and protein inhibitors are available. The inhibitors 
were removed and the method developed with PPE was performed. Results consistent with the 
potency of all three of the inhibitors tested were obtained. From these results, a fourth inhibitor is 
expected to be the best of the 7-substituted 4-chloro-3-ethoxyisocoumarin inhibitors of HLE. 
Publication of these results is planned. 
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